UBS Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.7M | Buy |
|
|||||
|
2025
Q1 | $24.1M | Buy |
|
|||||
|
2024
Q4 | $20M | Buy |
|
|||||
|
2024
Q3 | $4.01M | Buy |
|
|||||
|
2024
Q2 | $2.3M | Sell |
|
|||||
|
2024
Q1 | $4.75M | Buy |
|
|||||
|
2023
Q4 | $4.15M | Buy |
|
|||||
|
2023
Q3 | $1.5M | Sell |
|
|||||
|
2023
Q2 | $3.37M | Buy |
|
|||||
|
2023
Q1 | $1.98M | Sell |
|
|||||
|
2022
Q4 | $2.01M | Buy |
|
|||||
|
2022
Q3 | $466K | Buy |
|
|||||
|
2022
Q2 | $166K | Sell |
|
|||||
|
2022
Q1 | $806K | Sell |
|
|||||
|
2021
Q4 | $1.53M | Buy |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $299K | Sell |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $414K | Sell |
|
|||||
|
2020
Q3 | $382K | Buy |
|
|||||
|
2020
Q2 | $14K | Sell |
|
|||||
|
2020
Q1 | $11K | Sell |
|
|||||
|
2019
Q4 | $21K | Sell |
|
|||||
|
2019
Q3 | $143K | Sell |
|
|||||
|
2019
Q2 | $176K | Buy |
|
|||||
|
2019
Q1 | $205K | Buy |
|
|||||
|
2018
Q4 | $231K | Sell |
|
|||||
|
2018
Q3 | $637K | Buy |
|
|||||
|
2018
Q2 | $198K | Sell |
|
|||||
|
2018
Q1 | $250K | Sell |
|
|||||
|
2017
Q4 | $268K | Buy |
|
|||||
|
2017
Q3 | $61K | Buy |
|
|||||
|
2017
Q2 | $83K | Buy |
|
|||||
|
2017
Q1 | $9K | Sell |
|
|||||
|
2016
Q4 | $62K | Buy |
|
|||||
|
2016
Q3 | $28K | Buy |
|
|||||
|
2016
Q2 | $15K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $6K | Sell |
|
|||||
|
2015
Q2 | $9K | Buy |
|